These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27753007)

  • 21. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE.
    Angerer V; Mogler L; Steitz JP; Bisel P; Hess C; Schoeder CT; Müller CE; Huppertz LM; Westphal F; Schäper J; Auwärter V
    Drug Test Anal; 2018 Mar; 10(3):597-603. PubMed ID: 28670781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice.
    Wiley JL; Lefever TW; Marusich JA; Grabenauer M; Moore KN; Huffman JW; Thomas BF
    Neuropharmacology; 2016 Nov; 110(Pt A):143-153. PubMed ID: 27449567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Spicy Story of Cannabimimetic Indoles.
    Howlett AC; Thomas BF; Huffman JW
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA.
    Kevin RC; Wood KE; Stuart J; Mitchell AJ; Moir M; Banister SD; Kassiou M; McGregor IS
    J Psychopharmacol; 2017 Jun; 31(6):757-769. PubMed ID: 28093016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.
    Marusich JA; Wiley JL; Lefever TW; Patel PR; Thomas BF
    Neuropharmacology; 2018 May; 134(Pt A):73-81. PubMed ID: 29113898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.
    Castaneto MS; Gorelick DA; Desrosiers NA; Hartman RL; Pirard S; Huestis MA
    Drug Alcohol Depend; 2014 Nov; 144():12-41. PubMed ID: 25220897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects.
    Rodriguez JS; McMahon LR
    Eur J Pharmacol; 2014 Oct; 740():151-9. PubMed ID: 24972243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.
    Tai S; Hyatt WS; Gu C; Franks LN; Vasiljevik T; Brents LK; Prather PL; Fantegrossi WE
    Pharmacol Res; 2015 Dec; 102():22-32. PubMed ID: 26361728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection.
    Marshell R; Kearney-Ramos T; Brents LK; Hyatt WS; Tai S; Prather PL; Fantegrossi WE
    Pharmacol Biochem Behav; 2014 Sep; 124():40-7. PubMed ID: 24857780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.
    Canazza I; Ossato A; Vincenzi F; Gregori A; Di Rosa F; Nigro F; Rimessi A; Pinton P; Varani K; Borea PA; Marti M
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.
    Wiley JL; Lefever TW; Cortes RA; Marusich JA
    Pharmacol Biochem Behav; 2014 Sep; 124():123-8. PubMed ID: 24887450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of structural characteristics on the binding of synthetic cannabinoids from the JWH family to the CB1 receptor: A computational study.
    Chaturvedi K; Anthony CS; Pandey P; Doerksen RJ; Godfrey M
    J Mol Graph Model; 2024 Jan; 126():108620. PubMed ID: 37722351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.
    Rajasekaran M; Brents LK; Franks LN; Moran JH; Prather PL
    Toxicol Appl Pharmacol; 2013 Jun; 269(2):100-8. PubMed ID: 23537664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining Steric Requirements at CB
    Markham J; Sparkes E; Boyd R; Chen S; Manning JJ; Finlay D; Lai F; McGregor E; Maloney CJ; Gerona RR; Connor M; McGregor IS; Hibbs DE; Glass M; Kevin RC; Banister SD
    ACS Chem Neurosci; 2022 Apr; 13(8):1281-1295. PubMed ID: 35404067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
    Darmani NA; Janoyan JJ; Crim J; Ramirez J
    Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018.
    Gamage TF; Barrus DG; Kevin RC; Finlay DB; Lefever TW; Patel PR; Grabenauer MA; Glass M; McGregor IS; Wiley JL; Thomas BF
    Pharmacol Biochem Behav; 2020 Jun; 193():172918. PubMed ID: 32247816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.
    Brents LK; Gallus-Zawada A; Radominska-Pandya A; Vasiljevik T; Prisinzano TE; Fantegrossi WE; Moran JH; Prather PL
    Biochem Pharmacol; 2012 Apr; 83(7):952-61. PubMed ID: 22266354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
    Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
    Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB
    Pike E; Grafinger KE; Cannaert A; Ametovski A; Luo JL; Sparkes E; Cairns EA; Ellison R; Gerona R; Stove CP; Auwärter V; Banister SD
    Drug Test Anal; 2021 Jul; 13(7):1383-1401. PubMed ID: 33787091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug discrimination properties and cytotoxicity of the cannabinoid receptor ligands].
    Tomiyama K; Funada M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Jun; 47(3):135-43. PubMed ID: 22894054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.